14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
×
Home
/
Stock Analysis
/
Compare Terminal
/
XPH vs AMD
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
XPH vs AMD: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
AMD Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 9–1 Matrix Metrics)
AMD Overall Winner
6-Pillar Tally: XPH 0 – 6 AMD
Matrix Metrics: XPH 1 – 9 AMD
As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over SPDR S&P Pharmaceuticals ETF (XPH) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). XPH carries a Unified Composite Score of 41.0/100 (SELL) at $65.58 (N/M Forward P/E, N/A operating margin), whereas AMD carries 48.9/100 (HOLD) at $508.41 (30.2x Forward P/E, 17.8% operating margin).
XPH
NYSE Arca
SPDR S&P Pharmaceuticals ETF
Institutional Equity
Market Cap
N/A
TTM Revenue
N/A
Forward P/E
N/M
Beta / 30D Vol
0.87β · 32% Vol
Unified Composite Score
41.0 / 100
SELL
Tech 37.0
Fund 45.0
Flow 50.0
Mom 50.0
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.5 · SMA20: $65.05 · SMA50: $65.32
AMD
NASDAQ
Head-to-Head Winner
Advanced Micro Devices
Semiconductors & Related Devices
Market Cap
$959.9B
TTM Revenue
$45.4B
Forward P/E
30.2x
Beta / 30D Vol
3.60β · 118% Vol
Unified Composite Score
48.9 / 100
HOLD
Tech 23.0
Fund 42.0
Flow 68.0
Mom 37.6
Weinstein Technical Phase
Neutral · Hold
Mixed signals - no dominant trend phase, RSI 47
RSI-14: 47.0 · SMA20: $517.43 · SMA50: $555.12
6-Pillar Scorecard Institutional Category Breakdown (XPH 0 – 6 AMD)
Columns: Metric · XPH · AMD
1. Valuation Multiples
AMD
Forward P/E
N/M
30.2x
Trailing P/E
N/M
125.1x
PEG Ratio
N/M
0.50x
EV / Revenue
N/M
21.2x
2. Growth & Scale
AMD
Revenue Growth (YoY)
N/A
+44.7%
Earnings Growth (YoY)
N/A
+93.8%
TTM Revenue (USD)
N/A
$45.4B
Market Cap
N/A
$959.9B
3. Profitability & Quality
AMD
Gross Margin
N/A
56.0%
Operating Margin
N/A
17.8%
Net Profit Margin
N/A
16.8%
Return on Equity (ROE)
N/A
12.0%
4. Balance Sheet & Cash Flow
AMD
Cash Generation (TTM)
N/A
$7.06B
Cash Flow Margin
N/A
15.5%
Net Cash / Leverage
N/A ROE
$1.51B Net Debt (0.13x D/E)
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
AMD
Options Structure Phase
UNCLASSIFIED
CONSOLIDATION
Current IV / %ile
20.9% (5th %ile)
78.1% (10th %ile)
Put/Call OI Skew
N/A
1.07x (Balanced)
OBV Trend / Tech Phase
NEUTRAL · Neutral
ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat
AMD
OpEx & R&D Intensity
N/A
38.2% of Rev ($17.4B)
90D R&D Disclosures
0 papers
7 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Concentrated Oligopoly Moat
Supply-Chain Role
Institutional Equity Operator
AI Accelerator & Server Chiplet Designer
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: XPH (1) vs AMD (9)
Institutional Metric
XPH
AMD
Criterion
Row Edge
Market Capitalization
Scale
N/A
$959.9B
Larger Scale
AMD
Trailing P/E Ratio
Valuation
N/M
125.1x
Lower Multiple
AMD
Forward P/E Ratio
Valuation
N/M
30.2x
Lower Multiple
AMD
Revenue Growth (YoY)
Growth
N/A
+44.7%
Higher Growth
AMD
Operating Margin (TTM)
Profitability
N/A
17.8%
Higher Margin
AMD
Net Profit Margin
Profitability
N/A
16.8%
Higher Margin
AMD
Return on Equity (ROE)
Capital Efficiency
N/A
12.0%
Higher ROE
AMD
52-Week Range Position
Momentum
64% ($50–$74)
68% ($188–$659)
Stronger Trend
AMD
Beta / 30D Volatility
Risk Regime
0.87β · 32% Vol
3.60β · 118% Vol
Lower Realized Risk
XPH
Unified Institutional Score
Composite Signal
41.0 / 100 (SELL)
48.9 / 100 (HOLD)
Higher Composite
AMD
Trailing 12M Revenue (USD)
Operating Scale
N/A
$45.4B
FX-Normalized USD
Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A
56.0%
Higher Margin
Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev
0.50x PEG · 21.2x EV/Rev
Lower Multiple
Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE)
$7.06B ($1.51B Net Debt (0.13x D/E))
Higher Cash / Net Cash
Solvency
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M
3M
6M
1Y
1M Horizon
XPH +9.9 pp
XPH:
+6.05%
·
AMD:
-3.85%
3M Horizon
AMD +14.44 pp
XPH:
-9.48%
·
AMD:
+4.96%
6M Horizon
AMD +3.18 pp
XPH:
+17.59%
·
AMD:
+20.77%
1Y Horizon
AMD +74.43 pp
XPH:
+30.61%
·
AMD:
+105.04%
Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)
Split-Invariant USD Revenue & Operating Margin (%)
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on XPH vs AMD. Trailing 12-month operating profitability (XPH N/A vs AMD 17.8%) and valuation multiples (XPH N/M vs AMD 30.2x Forward P/E) are benchmarked directly in Pillar 4 below.
XPH ADR TTM Benchmark
FX-Normalized USD
TTM Revenue N/A
Gross Margin N/A
Op. Margin N/A
ROE / Fwd P/E N/A · N/M
AMD ADR TTM Benchmark
FX-Normalized USD
TTM Revenue $45.4B
Gross Margin 56.0%
Op. Margin 17.8%
ROE / Fwd P/E 12.0% · 30.2x
XPH
UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV
20.9%
IV Percentile
5th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
AMD
CONSOLIDATION
103d in phase · OBV ACCUMULATION
Current IV
78.1%
IV Percentile
10th %ile
Put/Call OI Skew
1.07x (Balanced)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
$500.00
Call Wall Magnet
$600.00
Net Delta Signal
NEUTRAL
OBV Flow
ACCUMULATION
Put Floor: $500.00 (-1.7%)
Spot: $508.41
Call Magnet: $600.00 (+18.0%)
XPH Moat Profile
Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
AMD Moat Profile
Concentrated Oligopoly Moat
AI Accelerator & Server Chiplet Designer
Data center GPU accelerators and server CPU chiplets scale directly with upstream leading-edge foundry utilization and cloud server integration.
OpEx & R&D Reinvestment
38.2% of Rev ($17.4B)
90D Engineering Disclosures
7 Published · LLM Efficiency / Architecture
Mapped Supply-Chain Ecosystem (18 partners):
Taiwan Semiconductor Manufacturing Company
GlobalFoundries
Samsung Electronics
ASE Technology Holding
Active 90D Technical Topics:
Edge AI / Inference Chips
Hardware-Agnostic ML Compilers
Inference Serving / Speculative Decoding
KV-Cache / Attention Memory Compression
Mixture-of-Experts / Sparse Models
Investor FAQ XPH vs AMD Key Questions & Quantitative Answers
Is XPH or AMD a better stock to buy right now?
As of Nov 16, 2026, Advanced Micro Devices (AMD) is the stronger overall head-to-head candidate over SPDR S&P Pharmaceuticals ETF (XPH) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). XPH carries a Unified Composite Score of 41.0/100 (SELL) at $65.58 (N/M Forward P/E, N/A operating margin), whereas AMD carries 48.9/100 (HOLD) at $508.41 (30.2x Forward P/E, 17.8% operating margin). Technically, XPH sits in a Neutral phase (RSI 51.5, UNCLASSIFIED options structure) and AMD sits in a Neutral phase (RSI 47.0, CONSOLIDATION options structure).
Does XPH or AMD have stronger revenue and earnings growth?
AMD leads the Growth & Scale pillar: XPH posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with AMD at +44.7% YoY revenue growth and +93.8% YoY earnings growth on $45.4B TTM revenue (56.0% gross margin, 17.8% operating margin). On trailing 12-month operating scale, XPH generates N/A in USD-normalized revenue versus $45.4B for AMD. In operating R&D and SG&A reinvestment, XPH deploys N/A (0 90-day corporate R&D disclosures) versus 38.2% of Rev ($17.4B) (7 disclosures) for AMD.
Is XPH or AMD cheaper on valuation?
AMD screens cheaper on headline valuation multiples. XPH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas AMD trades at 30.2x Forward P/E, 125.1x Trailing P/E, 0.50x PEG, and 21.2x EV/Revenue (15.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against XPH (N/A ROE) versus AMD (12.0% ROE) capital efficiency.
How is options market volatility positioned on XPH vs AMD?
In options market volatility and institutional positioning, XPH carries 20.9% implied volatility (5th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.87β · 32% Vol realized risk). By comparison, AMD carries 78.1% implied volatility (10th %ile, Compressed (<25th %ile)), a 1.07x (Balanced) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (3.60β · 118% Vol realized risk).
SPDR S&P Pharmaceuticals ETF (XPH) Research Suite
Advanced Micro Devices (AMD) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.